Commenting on the study for heartwire, antiplatelet expert Dr Victor Serebruany (HeartDrug Research, Towson, MD) said: "This is an extremely important paper with a clear clinical message—abrupt ...

Please provide your email address to receive an email when new articles are posted on . In early 2009, the FDA announced an ongoing safety review of clopidogrel after receiving reports that the use of ...

In January 2008, Dr Steven Steinhubl announced that he was leaving his academic position to join The Medicines Company. Although Steinhubl had no official relationship with the company at the time he ...

Add Yahoo as a preferred source to see more of our stories on Google. Clopidogrel is a once-a-day pill that is available under the brand names Grepid and Plavix Two million prescription for aspirin ...

You have full access to this article via your institution. The Clopidogrel as Adjunctive Reperfusion Therapy–Thrombolysis In Myocardial Infarction study (CLARITY-TIMI) 28 trial was an international, ...

For decades, aspirin has been the go‑to drug for preventing heart attacks and strokes. But recent research is turning that assumption on its head. Aspirin has been overtaken by another well-known ...

A research team led by Professors Joo-Yong Hahn, Young Bin Song, and Ki Hong Choi of the Division of Cardiology at Samsung ...

Clopidogrel is prescribed to help prevent cardiovascular events such as heart attack and stroke in certain adults. It’s a generic medication that's available as the brand-name drug Plavix. The drug ...

The antiplatelet drug clopidogrel helps prevent stent-associated thrombosis, but the antiplatelet effects are quite variable and the clinical consequences can be serious. New findings show that the ...

(HealthDay)—Vitamin K antagonists (VKA) combined with clopidogrel may be a better alternative to triple anticoagulant therapy in patients on long-term VKA undergoing percutaneous coronary intervention ...

Gaspoz et al. (June 6 issue) 1 present an interesting perspective on the problem of escalating health care costs. Their comparison between the cost effectiveness of aspirin and that of clopidogrel is ...

Ticagrelor may not have an advantage over clopidogrel as part of a dual antiplatelet therapy (DAPT) regimen when it comes to treating ACS patients who have undergone PCI in everyday practice, a large ...